Figure 10

Marked reduction of brain plaque load in TASD-41 APP transgenic mice following 30-days of intraperitoneal injections of PTI-777. 6 month old TASD-41 APP transgenic mice were injected daily with saline or PTI-777. Within 30 days, PTI-777 reduced % Aβ plaque load by 33.2% (p < 0.05) and plaque number (per sq. mm) by 55.6% (p < 0.01). **p < 0.05; ***p < 0.001, by Student’s t-test. Bars represent mean +/− SEM. n = 8 per group.